Learn More
Medchemexpress LLC RBN-3143 | 2360853-16-1 | C22H28FN3O4S | 50 MG

Supplier: Medchemexpress LLC HY15020750MG
RBN-3143 is a potent and NAD+-competitive catalytic PARP14 inhibitor with an IC50 value of 4 nM. It inhibits PARP14-mediated ADP-ribosylation and stabilizes PARP14 in cell lines. RBN-3143 can be used in research of lung inflammation and has been shown to improve steroid-resistant asthma mouse models.
- Potent and NAD+-competitive catalytic PARP14 inhibitor with an IC50 value of 4 nM
- Inhibits PARP14-mediated ADP-ribosylation
- Stabilizes PARP14 in cell lines
- Can be used in research of lung inflammation
- Improves steroid-resistant asthma mouse models
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.